Clinical Trial Update: Optimizing CNS DHA Delivery in Elderly Adults at Risk for Dementia [NA]

View source ↗

Summary

A clinical trial sponsored by the University of Cincinnati is investigating optimized CNS delivery of docosahexaenoic acid (DHA) for elderly adults at risk of d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia

Drugs mentioned

• Docosahexaenoic acid (docosahexaenoic acid)

Snippet

Sponsor: University of Cincinnati | Conditions: Eldery People, Cognitive Decline | NA | Status: RECRUITING